AL
Valbiotis S.A.
ALVAL.PA · PAR
0.79 € -2.83% (-0.02 €)
1M -1.70%
Market Cap 28.1M €
P/E Ratio -
Div. Yield -
ROE 82.07%
Piotroski F-Score Weak
1/9Valuation
25 /100
Expensive P/B 4.03x
P/S 31.02x
PEG N/A
Growth
34 /100
Stable Book val. growth 19.44%
Rev. growth 4.86%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 904.86%
Op. margin 1,049.06%
Gross margin 128.84%
Quality
1 /100
Poor Asset turnover 0.06x
ROA 65.45%
ROIC 77.97%
Debt
78 /100
Low Current ratio 2.85x
Debt/Equity 0.73x
Net debt/EBITDA N/A
Stability
33 /100
Unstable Profitable years 0
EPS volatility 30.32%
Beta -0.20x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o ALVAL.PA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sebastien Peltier
Employees
50
Headquarters
Périgny